Skip to main content

NCBiotech News

  • Joellen Harper Austin, executive officer at the National Institute of Neurological Disorders and Stroke, moved to the Triangle from Maryland early this summer to become the associate director for management at the National Institute of Environmental Health Sciences in Research Triangle Park. More
  • The North Carolina Biotechnology Center has awarded $1,378,772 in grants to six North Carolina universities in 2011 to boost biotechnology research. The 12 Institutional Development Grants (IDGs), matched at least 25 cents on the dollar by the universities, went to scientists at the University of North Carolina at Chapel Hill, Duke University, North Carolina State University, East Carolina University, the University of North Carolina at Greensboro and the University of North Carolina Wilmington.
  • Three physicians -- two in Greenville and one in Wilson -- recruited the highest number of patient/volunteers among 60 doctors’ offices nationwide participating in a cholesterol-therapy study conducted for Isis Pharmaceuticals Co. by Greenville-based site-specific contract research organization CTMG. More
  • The First Flight Venture Center (FFVC) in Research Triangle Park is accepting applications from life-science entrepreneurs who need a good place to start their business. FFVC has been incubating start-up companies for the past two decades, and has expanded its ability to help life science companies with the help of two Regional Development Grants from the North Carolina Biotechnology Center.
  • Icagen has become the latest North Carolina pharmaceutical company to be taken over by a multinational. Pfizer and Icagen today announced plans to let the drug giant pay $6 a share, or $56 million, to buy the remaining shares of the Research Triangle Park-based company that it doesn’t already own.
  • Greenville-based contract research organization CTMG has opened a new Raleigh office and closed its Wilson office. More
  • Teacher Mark Case (left)  examines sea-life samples with Biotech Center Education & Training Program Director Bill Schy and Emily Schultz, daughter of Marine Lab scientist Tom Schultz. Emily assisted at the workshop.
  • Students across North Carolina are getting hands-on introductions to futures in biotechnology through $486,000 in North Carolina Biotechnology Center grants. The 12 Educational Enhancement Grants (EEGs) from the Biotechnology Center’s most recent round of awards, ranging from $6,000 to more than $85,000, include:
  • It’s now or … next year. If you’re a leader of a young life-science company, tomorrow, July 13, is the last day to submit your online application to strut your company’s investment-worthy stuff to targeted investors, VCs and potential partners at the 2011 SEBIO Investor Forum. The forum itself doesn’t happen until November 2 and 3 at Durham’s Washington Duke Inn & Golf Club. But the lineup of companies will be determined now.
  • Steven Nichtberger, M.D., has resigned as president, CEO and board member of Tengion, a Pennsylvania company commercializing regenerative medicine discoveries of Wake Forest University scientist Anthony Atala, M.D. More
  • Mark Phillips, Executive Director of the North Carolina Biotechnology Center, Eastern Region, presents Roger Conner, Interim Director of Go-Science, sponsorship funds for STEM  (Science, Technology, Engineering and Mathmatics summer camps. -Thomasyne Jefferson
  • Mark Phillips, Executive Director of the North Carolina Biotechnology Center, Eastern Region, presents John Bray, Executive Director, A Time for Science, sponsorship funds to assist with STEM (Science, Technology, Engineering and Mathmatics) Summer camps for the youth. -Thomasyne Jefferson
  • BioPontis Alliance has added Pfizer and Janssen Biotech to its list of collaborators that are commercializing drug research from the University of North Carolina at Chapel Hill and other institutions. The Raleigh company announced the agreements this week at the 2011 BIO International Convention in Washington, D.C.
  • The revolutionary flu vaccine being developed by Medicago for production in its nearly completed Research Triangle Park manufacturing facility is behaving just as the company hoped.
  • Pappas Ventures' managing partner Arthur M. Pappas has some advice for startups today at BIO 2011 in Washington D.C. The session topic is "Starting Up Biotechs in the New Normal." With talk at the Ernst and Young panel on Tuesday about doing more with less, Pappas and his fellow panel members will have valuable advice for those trying to make it in life sciences today. The panel begins at 10 a.m.  in room 149 A/B.
  • Whether the issue is partnering, supply chain or the next big thing in ag biotech, you'll find your answer at the Walter E. Washington Convention Center today. And North Carolina speakers have those answers. Today's topic titles themselves are filled with questions:
  • Amy Schaberg, former vice president of clinical research at Inspire Pharmaceuticals, has been hired as vice president of operations at the fast-growing Chapel Hill contract research organization Rho. More
  • It’s a big deal for North Carolina and the global agricultural biotechnology world, so the groundbreaking for Syngenta Biotechnology’s $70 million expansion today required a big shovel – in this case, an excavator made by North Carolina-based Volvo Construction Equipment.
  • A new crop of life-science companies is putting North Carolina on the map with some of the world's most efficient manufacturing plants. The companies are unique because plants are their plants – living bioreactors producing therapeutics, diagnostics and other valuable biological products.
  • The Research Triangle area is ready to fly high in July, connecting with more than 13 million people via a 38-page special section in the Delta Airlines Sky magazine.


Subscribe to News & Events